Join us for an engaging discussion on Subcutaneous Administration Considerations, featuring Angel Luis Rivera, RN, BSN, MS, Clinical Nurse Consultant in Hematology/Oncology representing Los Angeles, and Kara Medina, RN, BSN, MS, Clinical Nurse Consultant in Hematology & Oncology representing Southern California and Hawaii. Both are esteemed members of the Bristol Myers Squibb team.

Learning Objectives and Key Discussion Points:

• Indications for Opdivo Qvantig (nivolumab-hyaluronidase-nvhy)
• Overview of the Phase 3 Checkmate 67T clinical trial
• Dosing considerations
• Subcutaneous administration insights
• Preparation and administration techniques

Registration is open to all medical personnel (non-industry) and is required to attend and participate in the discussion. 

Should you have any questions, please reach out to [email protected]

Webinar is sponsored by Bristol Myers Squibb.